Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julie Faber"'
Autor:
Nils E. Magnusson, Cecilie Budolfsen, Johann Bauer, Marcus Krüger, Daniela Grimm, Julie Faber, Markus Wehland, Manfred Infanger
Publikováno v:
Budolfsen, C, Faber, J, Grimm, D, Krüger, M, Bauer, J, Wehland, M, Infanger, M & Magnusson, N E 2019, ' Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment ', Current Vascular Pharmacology, vol. 17, no. 6, pp. 618-634 . https://doi.org/10.2174/1570161117666190130165810
Cancer treatment is an area of continuous improvement. Therapy is becoming more targeted and the use of anti-angiogenic agents in multiple cancers, specifically tyrosine kinase inhibitors (TKIs), has demonstrated prolonged survival outcomes compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39ba6b247abe83ec719ad09f681d59c
https://doi.org/10.2174/1570161117666190130165810
https://doi.org/10.2174/1570161117666190130165810
Publikováno v:
Faber, J, Hvas, A-M, Kristensen, S D, Grove, E L & Adelborg, K 2021, ' Immature Platelets and Risk of Cardiovascular Events among Patients with Ischemic Heart Disease : A Systematic Review ', Thrombosis and Haemostasis, vol. 121, no. 5, 200595, pp. 659-675 . https://doi.org/10.1055/s-0040-1721386
Background Immature platelets are larger and may be more thrombogenic than mature platelets. This systematic review included studies on the association between mean platelet volume (MPV), immature platelet count (IPC), and immature platelet fraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d436db97daedd3bdf529b8906c71382
https://pubmed.ncbi.nlm.nih.gov/33302302
https://pubmed.ncbi.nlm.nih.gov/33302302